Bioxyne Limited Director’s Interest Update

Bioxyne Limited (AU:BXN) has released an update.

Bioxyne Limited has announced a change in director Anthony Ho’s interests, with the acquisition of 5 million unlisted options approved by shareholders. The options have an exercise price of $0.02 and expire in December 2027. This change aligns with the company’s strategic decisions and reflects shareholder support.

For further insights into AU:BXN stock, check out TipRanks’ Stock Analysis page.